Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief

This article was originally published in The Gold Sheet

Executive Summary

It’s time to comment on ICH Q11
Advertisement

Related Content

Regulators Closer to Harmonizing QbD Review Approaches Under Pilot
Industry, Regulators Divided Over Q11 Definition of API Starting Materials
Drug Shortages Are A Matter Of Time As Bill Sponsors Work To Show Warnings Will Help
ICH Q11 Aims to Harmonize Principles for Drug Substance Development and Choice of Starting Materials
ICH Q11 Aims to Harmonize Principles for Drug Substance Development and Choice of Starting Materials
Advertisement
UsernamePublicRestriction

Register

PS000606

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel